Postprandial serum C-peptide is a useful parameter in the prediction of successful switching to liraglutide monotherapy from complex insulin therapy in Japanese patients with type 2 diabetes. (Q51353107)
Jump to navigation
Jump to search
scientific article published on 3 August 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Postprandial serum C-peptide is a useful parameter in the prediction of successful switching to liraglutide monotherapy from complex insulin therapy in Japanese patients with type 2 diabetes. |
scientific article published on 3 August 2012 |
Statements
Postprandial serum C-peptide is a useful parameter in the prediction of successful switching to liraglutide monotherapy from complex insulin therapy in Japanese patients with type 2 diabetes. (English)
1 reference
Tadashi Iwao
1 reference
Kenji Sakai
1 reference
Michio Sata
1 reference
3 August 2012
1 reference
27
1 reference
1
1 reference
87-91
1 reference